Diffusion-weighted MR Imaging: Diagnosing Atypical or Malignant Meningiomas and Detecting Tumor Dedifferentiation

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2008 Mar 22

PMID 18356472

Citations 67

Authors

V A Nagar

J R Ye

W H Ng

Y H Chan

F Hui

C K Lee

C C T Lim

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Atypical and malignant meningiomas are uncommon tumors with aggressive behavior and higher mortality, morbidity, and recurrence compared with benign tumors. We investigated the utility of diffusion-weighted (DW) MR imaging to differentiate atypical/malignant from benign meningiomas and to detect histologic dedifferentiation to higher tumor grade.

Materials And Methods: We retrospectively compared conventional and DW MR images (b-value 1000 s/mm(2)) acquired on a 1.5T clinical scanner between 25 atypical/malignant and 23 benign meningiomas. The optimal cutoff for the absolute apparent diffusion coefficient (ADC) and normalized ADC (NADC) ratio to differentiate between the groups was determined by using receiver operating characteristic (ROC) analysis.

Results: Irregular tumor margins, peritumoral edema, and adjacent bone destruction occurred significantly more often in atypical/malignant than in benign meningiomas. The mean ADC of atypical/malignant meningiomas (0.66 +/- 0.13 x 10(-3) mm(2)/s) was significantly lower compared with benign meningiomas (0.88 +/- 0.08 x 10(-3) mm(2)/s; P < .0001). Mean NADC ratio in the atypical/malignant group (0.91 +/- 0.18) was also significantly lower than the benign group (1.28 +/- 0.11; P < .0001), without overlap between groups. ROC analysis showed that ADC and NADC thresholds of 0.80 x 10(-3) mm(2)/s and 0.99, respectively, had the best accuracy: at the NADC threshold of 0.99, the sensitivity and specificity were 96% and 100%, respectively. Two patients had isointense benign tumors on initial DW MR imaging, and these became hyperintense with the decrease in ADC and NADC below these thresholds when they progressed to atypical and malignant meningiomas on recurrence.

Conclusions: ADC and NADC ratios in atypical/malignant meningiomas are significantly lower than in benign tumors. Decrease in ADC and NADC on follow-up imaging may suggest dedifferentiation to higher tumor grade.

Citing Articles

Malignant Meningiomas: From Diagnostics to Treatment.

Rowbottom H, Smigoc T, Ravnik J Diagnostics (Basel). 2025; 15(5).

PMID: 40075786 PMC: 11898517. DOI: 10.3390/diagnostics15050538.

Merlin phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging features.

Eaton C, Avalos L, Liu S, Chen Z, Zakimi N, Casey-Clyde T Nat Commun. 2024; 15(1):7873.

PMID: 39251601 PMC: 11383945. DOI: 10.1038/s41467-024-52284-8.

The Impact of Molecular and Genetic Analysis on the Treatment of Patients with Atypical Meningiomas.

Ravnik J, Rowbottom H Diagnostics (Basel). 2024; 14(16).

PMID: 39202270 PMC: 11353905. DOI: 10.3390/diagnostics14161782.

Papillary meningioma with prominent flow voids.

Panigrahi M, Bodhey N, Singh V, Nehete L SA J Radiol. 2024; 28(1):2778.

PMID: 38628267 PMC: 11019086. DOI: 10.4102/sajr.v28i1.2778.

Predicting Histologic Grade of Meningiomas Using a Combined Model of Radiomic and Clinical Imaging Features from Preoperative MRI.

Park J, Quang L, Yoon W, Baek B, Park I, Kim S Biomedicines. 2023; 11(12).

PMID: 38137489 PMC: 10741678. DOI: 10.3390/biomedicines11123268.

References

Fulham M, Bizzi A, Dietz M, Shih H, Raman R, Sobering G . Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology. 1992; 185(3):675-86. DOI: 10.1148/radiology.185.3.1438744. View

Vorisek I, Hajek M, Tintera J, Nicolay K, Sykova E . Water ADC, extracellular space volume, and tortuosity in the rat cortex after traumatic injury. Magn Reson Med. 2002; 48(6):994-1003. DOI: 10.1002/mrm.10305. View

Inaoka T, Takahashi K, Miyokawa N, Ohsaki Y, Aburano T . Solitary fibrous tumor of the pleura: apparent diffusion coefficient (ADC) value and ADC map to predict malignant transformation. J Magn Reson Imaging. 2007; 26(1):155-8. DOI: 10.1002/jmri.20942. View

KEPES J, Moral L, Wilkinson S, Abdullah A, Llena J . Rhabdoid transformation of tumor cells in meningiomas: a histologic indication of increased proliferative activity: report of four cases. Am J Surg Pathol. 1998; 22(2):231-8. DOI: 10.1097/00000478-199802000-00012. View

Floeth F, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider M . Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma. J Nucl Med. 2007; 48(4):519-27. DOI: 10.2967/jnumed.106.037895. View

Provenzale J, Engelter S, Petrella J, Smith J, MacFall J . Use of MR exponential diffusion-weighted images to eradicate T2 "shine-through" effect. AJR Am J Roentgenol. 1999; 172(2):537-9. DOI: 10.2214/ajr.172.2.9930819. View

Xu M, See S, Ng W, Arul E, Back M, Yeo T . Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery. 2005; 56(5):919-26. View

Shino A, Nakasu S, Matsuda M, Handa J, Morikawa S, Inubushi T . Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg. 1999; 91(6):928-34. DOI: 10.3171/jns.1999.91.6.0928. View

Zee C, Chin T, Segall H, Destian S, Ahmadi J . Magnetic resonance imaging of meningiomas. Semin Ultrasound CT MR. 1992; 13(3):154-69. View

10.

Milosevic M, Frost P, Laperriere N, Wong C, Simpson W . Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys. 1996; 34(4):817-22. DOI: 10.1016/0360-3016(95)02166-3. View

11.

Krabbe K, Gideon P, Wagn P, Hansen U, Thomsen C, Madsen F . MR diffusion imaging of human intracranial tumours. Neuroradiology. 1997; 39(7):483-9. DOI: 10.1007/s002340050450. View

12.

Szafer A, Zhong J, Anderson A, Gore J . Diffusion-weighted imaging in tissues: theoretical models. NMR Biomed. 1995; 8(7-8):289-96. DOI: 10.1002/nbm.1940080704. View

13.

Jaaskelainen J, Haltia M, Laasonen E, Wahlstrom T, Valtonen S . The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol. 1985; 24(2):165-72. DOI: 10.1016/0090-3019(85)90180-6. View

14.

Carpeggiani P, Crisi G, Trevisan C . MRI of intracranial meningiomas: correlations with histology and physical consistency. Neuroradiology. 1993; 35(7):532-6. DOI: 10.1007/BF00588715. View

15.

Schubert M, Wilke M, Muller-Weihrich S, Auer D . Diffusion-weighted magnetic resonance imaging of treatment-associated changes in recurrent and residual medulloblastoma: preliminary observations in three children. Acta Radiol. 2006; 47(10):1100-4. DOI: 10.1080/02841850600990300. View

16.

Yang G, Tan Y, Loh S, Lim C . Neuroradiology imaging database: using picture archive and communication systems for brain tumour research. Singapore Med J. 2007; 48(4):342-6. View

17.

Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K . The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol. 2001; 22(6):1081-8. PMC: 7974804. View

18.

Mahmood A, Caccamo D, Tomecek F, Malik G . Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery. 1993; 33(6):955-63. DOI: 10.1227/00006123-199312000-00001. View

19.

Verheggen R, Finkenstaedt M, Bockermann V, Markakis E . Atypical and malignant meningiomas: evaluation of different radiological criteria based on CT and MRI. Acta Neurochir Suppl. 1996; 65:66-9. DOI: 10.1007/978-3-7091-9450-8_19. View

20.

Modha A, Gutin P . Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery. 2005; 57(3):538-50. DOI: 10.1227/01.neu.0000170980.47582.a5. View